Immediate Impact
2 from Science/Nature 72 standout
Citing Papers
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of K. Buckley being referenced
Medical Isotope Production at TRIUMF – from Imaging to Treatment
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| K. Buckley | 422 | 196 | 99 | 44 | 609 | |
| R.J. Nickles | 230 | 210 | 56 | 45 | 674 | |
| S.L. Waters | 262 | 151 | 86 | 36 | 515 | |
| Michael S. Kovacs | 338 | 87 | 162 | 36 | 570 | |
| J. Stĕpánek | 324 | 434 | 404 | 29 | 629 | |
| Gabriel K. Y. Lam | 265 | 370 | 442 | 52 | 661 | |
| H.W. Reist | 162 | 137 | 128 | 38 | 735 | |
| Jeffrey T. Cessna | 346 | 505 | 98 | 57 | 680 | |
| G. Baiocco | 185 | 200 | 401 | 54 | 619 | |
| Hayato Ikeda | 396 | 278 | 82 | 48 | 708 | |
| B. L. Zhuikov | 375 | 194 | 169 | 45 | 566 |
All Works
Loading papers...